Introduction
Premature ovarian failure (POF) is defined by hypergonadotrophic amenorrhoea occurring before the age of 40 years (Coulam et al., 1986) and is associated with oestrogenic deficiency and infertility. Chromosomal, enzymatic or exogenous causes including chemotherapy, radiotherapy and surgery are well documented. However, idiopathic primitive POF remains an important group which may depend on either a genetic or an immunological mechanism. Examples of a genetic basis of POF include the X chromosome deletion (Krauss et al., 1987; Veneman et al., 1991) and the infrequent autosomal gene deletion (Nicolino et al., 1995) . However, most genes involved in oogenesis development and function have not yet been identified, and new genetic causes are likely to be described in the future.
POF is considered as an immunological disease, and has been suggested for a long time to be associated with several factors, including autoimmune disease (Irvine et al., 1968; Vasquez and Kenny, 1973; Alper and Garner, 1985) , ovarian lymphocytic infiltration (Kinch et al., 1965; Tung and Lu, 1991) , detection of anti-ovarian antibodies (Luborsky et al., 1990; Wheatcroft et al., 1994) and post-immunotherapy reversibility (Corenblum et al., 1993) . Results of ovarian biopsies showing persistent follicles, identified more recently by ultrasonography (Mehta et al., 1992; Conway et al., 1996) , together with spontaneous (Szlachter et al., 1979) and post-hormonal therapy (Cowchock et al., 1988) pregnancies, can indeed suggest a partial, reversible autoimmune attack. It is therefore important from a practical point of view to determine objective immunological markers in order to aid diagnosis, prognosis and rational treatment. The presence of positive circulating ovarian antibodies (AOA) (Valloton and Forbes, 1996) is considered to be a suitable marker to identify the participation of an immunological mechanism in POF. However, as for other autoimmune diseases, problems with techniques and the interpretation of results have been raised (Moncayo and Moncayo, 1992) , especially with original immunohistochemical methods of detection (Rabinowe et al., 1989) . More recently, development of an enzyme-linked immunosorbent assay (ELISA) has improved the quality of detection (Luborsky et al., 1990; Wheatcroft et al., 1994) , together with the reproducibility, specificity and objective quantification of the results. Nevertheless, positive AOA have been found after surgery (Luborsky et al., 1990) , following in-vitro fertilization (IVF) oocyte recovery (Gobert et al., 1990) and even in Turner syndrome (Wheatcroft et al., 1994) , so that the real significance of circulating AOF must be questioned. Although the specificity of these antibodies can now be verified, it remains to be determined whether they are related to, associated with, or a consequence of the pathological process leading to POF (Moncayo and Moncayo, 1992) . Using a suitable ELISA based on human ovaries at different stages of differentiation (Gobert et al., 1992) , we have examined the frequency, specificity and significance of the presence of circulating AOA in idiopathic POF by comparison with several control groups (normally ovulating women, menopausal women, patients with other autoimmune diseases and non-immunological POF) and by looking for associated markers of autoimmunity.
Materials and methods

Patients and controls
Sera from 46 women with spontaneous POF were assessed for the presence of AOA and associated immunological markers. POF was defined by amenorrhoea with follicle stimulating hormone (FSH) Ͼ40 IU/l and plasma oestradiol Ͻ30 pg/ml. All patients were aged Ͻ40 years at the onset of ovarian failure and had not had ovarian and/or pelvic surgery except for diagnostic laparoscopy performed in 12 patients, had no dysmorphic clinical symptoms and had height Ͼ150 cm; normal 46 XX karyotype was verified for 21 patients. All patients were first seen at the Reproductive Endocrinology Department of Nice for either secondary amenorrhoea with hot flushes (22/46) and/or infertility (24/46).
Neither patients nor control subjects were receiving steroids at the time of blood sampling. Hormonal therapy began after checkup and included oestradiol valerate (Provames ® ; Lab. Cassenne, Paris, France) 2 mg/day for 25 days/month, and micronized progesterone (Utrogestan ® ; Lab. Besins-Iscovesco, Paris, France) 300 mg/day, from day 10 to day 25.
Control samples were obtained at the Nancy Health Survey Centre from 17 men and 23 women in the same age range (mean age 32 years) with no evidence of autoimmune disease or fertility problems. Women with untreated Grave's disease (n ϭ 35) or with positive antinuclear antibodies (n ϭ 25) were screened for associated or cross-reacting auto-antibodies. Postmenopausal women (n ϭ 40, mean age 56 years) and older women (n ϭ 15, mean age 86 years) were used as control groups to assess the significance of AOA.
Screening for anti-ovarian antibodies
An ELISA method, developed in the Immunology Laboratory of the Faculté de Médecine of Nancy (Gobert et al., 1990; Gobert et al., 1992) , and using as antigen ovarian soluble crude extract from several human ovaries at different ages, was chosen to assess the amount of serum AOA. Peroxidase conjugated antibodies to human IgG, IgA and IgM (ICN, Lisle, IL, USA) were used as second-step reagents to identify the amount of each specific isotype. Optical densities (OD) were measured at 492 nm using a MultiskanTiterlek spectrometer (Flow Laboratories, Helsinki, Finland) . Results were expressed as the ratio of the OD of each sample to the reference OD obtained using a standard pool of control sera. This ratio is equivalent to the mean OD Ϯ 2 SD obtained using the reduced variable method with control samples from normal healthy subjects. A ratio Ͼ1 was considered to be positive.
Immunological testing
Subjects were screened for other immunological markers associated with familial and/or personal associated autoimmune disease. Serum samples were evaluated for the presence of autoantibodies raised 
Statistical analysis
Comparison with control groups was made using a Mann-Whitney test for n Ͻ 30 and an unpaired Student's t-test for n Ͼ 30. Table I presents patients with primary idiopathic POF who were referred to our clinic either for infertility or for secondary amenorrhoea. Their mean age was 36 years (range 22-48) with a duration of secondary amenorrhoea of 5 years (range 0.5-21). In all, 59% (27/46) were positive for at least one AOA isotype. Patients who underwent laparoscopy with ovarian biopsy were equally distributed between subgroups AOA positive and AOA negative patients (Table I ). Figure 1 shows the values of the individual ratios for the three isotypes; 20/27 were positive for IgG, 8/27 for IgA and 9/27 for IgM. A majority of the POF negative values were found to be near the threshold value for all the isotypes.
Results
AOA prevalence
Specificity
Mean ratios for the three subclasses of immunoglobins shown in Figure 2 were clearly significantly higher for POF patients than for all control groups tested (P Ͻ 0.0001), with the exception of the group of women with positive antinuclear antibodies (ANA) whose IgA values were not significantly different. A search for possible cross-reactivity found that six out of 27 sera positive for AOA also reacted with other tissues (thyroid, pancreas, adrenal), including four patent clinical polyendocrinopathies (Table II) . 
Significance
When compared to postmenopausal or to older women, the AOA ratios for POF women were significantly higher for the three isotypes, as shown in Figure 3 . The time factor did not appear to influence AOA ratios (data not shown), except for IgM in the subgroup of patients (n ϭ 12) who underwent laparoscopy with ovarian biopsy (Figure 4 ). In this subgroup, IgM ratio was positively related (P Ͻ 0.02) to the time since the biopsy had been performed. Performance of a biopsy did not influence the AOA ratios (Table III) , since there was no difference in ratio between patients with or without a biopsy. None of the patients underwent other types of pelvic surgery. Screening for other autoimmune markers showed the presence of familial or personal associated autoimmune disease in nine cases, and anti-organ autoantibodies in 12 cases (Table II) . HLA DR3 was found in 24% (10/42), HLA DR4 in 26% (11/ 42) and HLA DR5 in 29% (12/42). None of these frequencies was significantly different from that of a French control population: DR3 24 versus 9%, P Ͻ 0.07; DR4 27 versus 5%, P Ͻ 0.05; DR5 29 versus 17%, NS, χ 2 test.
Pregnancies
Spontaneous pregnancies occurred in four cases out of 15 women who wished to conceive and who received oestrogen therapy. Three of these cases were AOA positive; one patient had a very high ratio of IgG (1.6), one had a ratio of 1.03 with associated hypoparathyroidism, one had a ratio of 1.0 and one had a ratio of 0.8. Post-fertilization ratios were not measured.
Discussion
Autoimmune oophoritis has been considered to be a mechanism possibly responsible for primary idiopathic POF. However, the frequency (Coulam et al., 1986) , physiopathology (Coulam and Ryan, 1985; Moncayo and Moncayo, 1992) and potential reversibility (Corenblum et al., 1993) of this ovarian disorder remain open to discussion. As for other autoimmune diseases, 
IDDM ϭ insulin-dependent diabetes mellitus, tpo ϭ thyroperoxidase, HT ϭ Hashimoto's thyroiditis, a ϭ adrenal, AD ϭ Addison's disease, β ϭ beta islets, sm ϭ smooth muscle.
screening for specific autoantibodies may represent the most suitable and practical way of evaluating the immunological process. The presence of positive AOA in POF has been reported, with a frequency of 20-69% (Coulam and Ryan, 1985; Damewood et al., 1986; Luborsky et al., 1990; Wheatcroft et al., 1994) , depending on the origin of the ovaries (animal or human), on the method used (immunofluorescence, radio-ligand binding, ELISA) and on the selection of patients.
Using an ELISA with human ovaries, we found a high frequency (59%) of circulating AOA in a group of 46 patients with primary POF without any malformation, whose height was Ͼ1.5 m, and a normal karyotype in 21 cases who were cytogenetically analysed. We confirm here the high frequency of positive circulating AOA in idiopathic POF reported by 2626 Wheatcroft et al. (1994) , using an ELISA against two different human ovaries (24 and 60% positive AOA) and by Luborsky et al. (1990) , using an ELISA against either complete ovary or oocytes (69% positive AOA). Are these ovarian antibodies specific? The ELISA applied in this study uses antigenic substrates extracted from several whole human ovaries of different ages, thus avoiding variations between ovaries (Wheatcroft et al., 1994) . This objective, quantitative and reproducible method is able to detect one or several antibodies raised against one or several ovarian antigens, including differentiation antigens and to permit their comparison. A clear cut-off between negative and positive sera was defined by considering as positive a ratio Ͼ1.0, when the OD was compared to the mean OD ϩ 2 SD obtained from a control group. It has been suggested that these AOA may cross-react with other tissues (Vasquez and Kenny, 1973) . A group of patients with untreated Grave's disease and a group with positive ANA were also tested in this study and found to be negative. In addition, sera positive for AOA were all tested against other tissues and only six out of 27 showed positive cross-reactivity. Four of these cases corresponded to a clinical autoimmune polyendocrinopathic state. Although the specific antigen (s) have not yet been identified it is likely that 2627 different antigens may be involved. Identification of the antigen(s) concerned will advance the understanding of POF physiopathology. Several candidates have been proposed. It was first suggested that resistant ovary syndrome was linked to the presence of antibodies raised against FSH (Chiauzzi et al., 1982; Van Weissenbruch et al., 1991) and/or LH receptors (Moncayo and Moncayo, 1992) . Systematic screening of such antibodies has been disappointing (Luborsky et al., 1990; Anasti et al., 1994; Lambert et al., 1996) . In the case of polyendocrinopathy, common antigens have been suggested but never demonstrated for ovarian tissue. We are currently investigating potential antigens using SDS-PAGE and Western blot. The significance of circulating AOA remains an essential question. The presence of elevated values of specific FSH isoforms has been considered to be a potential factor able to stimulate ovarian autoimmunity by overexpression of HLA DR antigen on the granulosa cells (Tidey et al., 1992) . It is possible that menopausal status could be associated with AOA. However, our POF group was found to be significantly different from postmenopausal and older women, thus eliminating such a hypothesis.
No relationship could be found with the duration of amenorrhoea, suggesting that AOA may still be detected late after the onset of menopause. In the subgroup of women who underwent a laparoscopy for diagnosis, only the IgM isotype was found to change with the time since an ovarian biopsy had been performed. It is possible that high levels of IgA might reflect high levels of AOA secreted around the ovaries in the peritoneal fluid where the immune system is relatively well developed. Detection of circulating AOA suggests the presence of an autoimmune process that could be the primary or secondary reaction to an ovarian aggression. It has been reported that mechanical aggression, such as IVF puncture (Gobert et al., 1990 (Gobert et al., ,1992 or post-traumatic castration (surgery, chemo-or radiotherapy), could expose differentiation antigens, similar to antisperm antibodies detected after vasectomy (Linnet, 1983) . However, in our primary POF group, no pelvic surgery had been performed and no difference was found between the patients with or without precedent biopsy; moreover, 21 out of the 27 positive patients did not undergo laparoscopy. This result eliminates mechanical factors as the main cause and suggests the operation of a primitive autoimmune mechanism in our POF patients. We have been investigating other immunological markers: associated autoimmune disease, autoantibodies, associated HLA antigens (Walfish et al., 1983; Anasti et al., 1994) . Screening for such markers supported our hypothesis, since 45% of AOA-positive patients had at least one other marker, while 26% of the negative patients had at least two other markers. Thus, AOA may evolve with time as for other auto-antibodies.
Concerning the four pregnancies which occurred during oestrogen therapy, three women had positive circulating AOA. However these assays were conducted prior to oestrogen therapy and were not repeated after fertilization. Luborsky et al. (1990) reported the decrease of AOA after steroid treatment in two cases of POF. Several studies (Blumenfeld et al., 1993; Barbarino-Monnier et al., 1995) have examined the treatment of POF patients with either oestrogens or corticosteroids with or without ovulation induction by HMG. A spontaneous pregnancy following a previous pregnancy oocyte donation has recently been reported in a patient with POF (Sheu et al., 1996) .
However, in a patient with POF, our results suggest that autoimmune ovaritis may be frequently associated with idiopathic primary POF. AOA determination by ELISA represents a suitable marker for diagnosis and may help to determine the best way to restore ovulation. With positive AOA, a short and intensive course of corticosteroid therapy may be proposed, with AOA screening and ultrasonography before and after treatment. Because of the possibility of spontaneous remissions, randomized studies are needed to elucidate the real benefit of corticosteroid treatment. Such a study is in progress in our department.
